The deadly business of an unregulated global stem cell industry

Journal of Medical Ethics 43 (11):744-746 (2017)

Abstract

In 2016, the Office of the State Coroner of New South Wales released its report into the death of an Australian woman, Sheila Drysdale, who had died from complications of an autologous stem cell procedure at a Sydney clinic. In this report, we argue that Mrs Drysdale's death was avoidable, and it was the result of a pernicious global problem of an industry exploiting regulatory systems to sell unproven and unjustified interventions with stem cells.

Download options

PhilArchive



    Upload a copy of this work     Papers currently archived: 72,766

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2017-10-25

Downloads
11 (#859,638)

6 months
1 (#386,989)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Similar books and articles

The Stem Cell Uncertainty Principle.Melinda Bonnie Fagan - 2013 - Philosophy of Science 80 (5):945-957.
Stem Cell Research: An Ethical Evaluation of Policy Options.Nikolaus Knoepffler - 2004 - Kennedy Institute of Ethics Journal 14 (1):55-74.
Crucial Stem Cell Experiments? Stem Cells, Uncertainty, and Single-Cell Experiments.Melinda Bonnie Fagan - 2015 - Theoria: Revista de Teoría, Historia y Fundamentos de la Ciencia 30 (2):183-205.
Towards a Global Human Embryonic Stem Cell Bank.Jason P. Lott & Julian Savulescu - 2007 - American Journal of Bioethics 7 (8):37 – 44.
Social Experiments in Stem Cell Biology.Melinda B. Fagan - 2011 - Perspectives on Science 19 (3):235-262.
Moral Complicity in Induced Pluripotent Stem Cell Research.Mark T. Brown - 2009 - Kennedy Institute of Ethics Journal 19 (1):pp. 1-22.
Stem Cell Stories: From Bedside to Bench.S. Woods - 2008 - Journal of Medical Ethics 34 (12):845-848.